DocSym
β
Searchsearch
Search
(B46.5) Mucormycosis, unspecified
More details coming soon
1 727 in individuals diagnosis mucormycosis, unspecified confirmed
2 784 deaths with diagnosis mucormycosis, unspecified
161% mortality rate associated with the disease mucormycosis, unspecified
Diagnosis mucormycosis, unspecified is diagnosed Men are 28.20% more likely than Women
1 107
Men receive the diagnosis mucormycosis, unspecified
2 068 (186.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
620
Women receive the diagnosis mucormycosis, unspecified
716 (115.5 %)Died from this diagnosis.
Risk Group for the Disease mucormycosis, unspecified - Men aged 15-19 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 35-39, 50-59
Less common in men the disease occurs at Age 0-14, 20-34, 40-49, 60-95+Less common in women the disease occurs at Age 0-64, 70-95+
In Women diagnosis is most often set at age 65-69
Disease Features mucormycosis, unspecified
Absence or low individual and public risk
Mucormycosis, unspecified - what does this mean
Mucormycosis is a rare fungal infection caused by a group of fungi called the mucorales. it typically occurs when a person inhales fungal spores in the air, although it can also be caused by direct contact with contaminated soil or decaying organic matter. it is most commonly seen in people with weakened immune systems, such as those with diabetes, cancer, or hiv/aids, or those who are taking immunosuppressive medications. symptoms can range from a mild skin rash to serious lung and brain infections.
What happens during the disease - mucormycosis, unspecified
Mucormycosis is a rare but potentially fatal infection caused by the inhalation of fungal spores from the environment, typically from soil or decaying organic matter. these spores enter the body through the respiratory tract and can spread to other organs, including the brain, sinuses, and lungs. risk factors for this infection include diabetes, immunosuppression, and other underlying medical conditions. once the spores enter the body, they can cause tissue destruction, inflammation, and necrosis. if left untreated, it can lead to life-threatening complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination to check for symptoms
- CT scans to check for lung involvement
- X-ray to check for bone involvement
- Blood tests to check for inflammation
- Sputum culture to check for the presence of the fungus
- Biopsy of the affected tissue to confirm the diagnosis
- Serological tests to detect antibodies
- MRI scans to check for brain involvement
Treatment and Medical Assistance
Main Goal: To treat Mucormycosis, unspecified
- Administer antifungal medications
- Perform surgical debridement to remove affected tissue
- Provide supportive care including nutritional support and oxygen therapy
- Administer hyperbaric oxygen therapy
- Monitor patient for signs of infection and complications
- Provide patient education on the disease and its potential complications
38 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Mucormycosis, unspecified - Prevention
Mucormycosis, unspecified can be prevented by avoiding contact with contaminated soil and water, as well as by wearing protective clothing when working outdoors. good hygiene practices, such as washing hands regularly and avoiding contact with infected individuals, can also help reduce the risk of infection. additionally, people with weakened immune systems should take extra precautions to avoid exposure.